A combined analysis of EORTC/MRC randomized clinical trials for the prophylactic treatment of TaT1 bladder cancer. Eortc Genito-Urinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer.
Pawinski
A
A
Memorial Cancer Center, Department of Urology, Warwaw, Poland.
Sylvester
R
R
Bouffioux
C
C
Kurth
K H
KH
Parmar
M
M
Bijnens
L
L
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002295:Carcinoma, Transitional Cell / Q000517:prevention & control* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D001749:Urinary Bladder Neoplasms / Q000517:prevention & control* / Q000601:surgery
D000970:Antineoplastic Agents